We are live on ! Find out more
Los Angeles Capital Management

Los Angeles Capital Management Portfolio holdings

AUM $25.4B
1-Year Est. Return 38.46%
This Fund
S&P 500
This Quarter Est. Return
-0.35%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$23.6B
AUM Growth
-$1.36B
Cap. Flow
-$773M
Cap. Flow %
-3.28%
Top 10 Hldgs %
34.03%
Holding
1,274
New
126
Increased
411
Reduced
478
Closed
172

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$343M
2
ISRG icon
Intuitive Surgical
ISRG
+$173M
3
ACN icon
Accenture
ACN
+$130M
4
HSY icon
Hershey
HSY
+$127M
5
DE icon
Deere & Co
DE
+$121M

Sector Composition

Rank Sector Weight
1 Technology 33.05%
2 Financials 13.6%
3 Consumer Discretionary 12.37%
4 Healthcare 10.63%
5 Industrials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMCL icon
1201
Omnicell
OMCL
$1.69B
-5,479
Closed -$404K
OXM icon
1202
Oxford Industries
OXM
$538M
-18,751
Closed -$1.85M
PAYC icon
1203
Paycom
PAYC
$9.52B
-290,198
Closed -$93.2M
PBH icon
1204
Prestige Consumer Healthcare
PBH
$2.48B
-16,488
Closed -$980K
PEN icon
1205
Penumbra
PEN
$12.9B
-679
Closed -$234K
PGEN icon
1206
Precigen
PGEN
$2.45B
-213,294
Closed -$245K
PHR icon
1207
Phreesia
PHR
$758M
-12,794
Closed -$397K
PLNT icon
1208
Planet Fitness
PLNT
$3.65B
-4,363
Closed -$294K
PLYA
1209
DELISTED
Playa Hotels & Resorts
PLYA
-29,276
Closed -$238K
PODD icon
1210
Insulet
PODD
$10.1B
-1,277
Closed -$368K
PRGO icon
1211
Perrigo
PRGO
$1.76B
-9,098
Closed -$309K
PRLB icon
1212
Protolabs
PRLB
$2.17B
-13,589
Closed -$475K
PTCT icon
1213
PTC Therapeutics
PTCT
$6.06B
-6,383
Closed -$260K
PTGX icon
1214
Protagonist Therapeutics
PTGX
$9.84B
-9,366
Closed -$259K
QDEL icon
1215
QuidelOrtho
QDEL
$1.02B
-3,976
Closed -$329K
RAPT
1216
DELISTED
RAPT Therapeutics
RAPT
-3,594
Closed -$538K
RBLX icon
1217
Roblox
RBLX
$25.4B
-10,634
Closed -$429K
RLMD icon
1218
Relmada Therapeutics
RLMD
$503M
-11,877
Closed -$29.2K
RS icon
1219
Reliance Steel & Aluminium
RS
$21.8B
-1,908
Closed -$518K
RVMD icon
1220
Revolution Medicines
RVMD
$44B
-11,614
Closed -$311K
RYZ
1221
Ryerson Holding Corp
RYZ
$1.5B
-29,103
Closed -$1.26M
SAIA icon
1222
Saia
SAIA
$9.73B
-1,259
Closed -$431K
SCSC icon
1223
Scansource
SCSC
$1.06B
-10,469
Closed -$309K
SGMO
1224
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-19,083
Closed -$24.8K
SIBN icon
1225
SI-BONE Inc
SIBN
$852M
-15,160
Closed -$409K

Similar funds

Los Angeles Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Los Angeles Capital Management held 1,274 positions worth $23.6B, down 5.5% from $24.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Los Angeles Capital Management withdrew a net $773M in Q3 2023, closing 172 positions and reducing 478 holdings. Its most notable exit was Paycom, an estimated $93.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Los Angeles Capital Management opened a new position in HF Sinclair worth $41.7M.

  • Los Angeles Capital Management's largest Q3 2023 buy was HF Sinclair: 732,971 shares worth $41.7M.
  • Los Angeles Capital Management added most to Berkshire Hathaway Class B in Q3 2023, an estimated $165M increase.
  • Los Angeles Capital Management's biggest Q3 2023 reduction was Broadcom, cutting an estimated $343M.
  • Los Angeles Capital Management fully exited Paycom in Q3 2023, selling an estimated $93.2M.
  • Los Angeles Capital Management's ten largest holdings make up 34% of its $23.6B portfolio in Q3 2023.
  • Los Angeles Capital Management opened 126 new positions and closed 172 in Q3 2023.
  • Los Angeles Capital Management's portfolio value fell 5.5% quarter-over-quarter to $23.6B.

Based on Los Angeles Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.